Table of Contents
Chapter 1 Overview of Lower Limb Exoskeleton
    1.1 Definition of Lower Limb Exoskeleton in This Report
    1.2 Commercial Types of Lower Limb Exoskeleton
        1.2.1 Powered
        1.2.2 Passive
    1.3 Downstream Application of Lower Limb Exoskeleton
        1.3.1 Healthcare
        1.3.2 DefenseandMilitary
        1.3.3 Industrial
    1.4 Development History of Lower Limb Exoskeleton
    1.5 Market Status and Trend of Lower Limb Exoskeleton 2016-2026
        1.5.1 Global Lower Limb Exoskeleton Market Status and Trend 2016-2026
        1.5.2 Regional Lower Limb Exoskeleton Market Status and Trend 2016-2026
Chapter 2 Global Market Status and Forecast by Regions
    2.1 Market Development of Lower Limb Exoskeleton 2016-2021
    2.2 Sales Market of Lower Limb Exoskeleton by Regions
        2.2.1 Sales Volume of Lower Limb Exoskeleton by Regions
        2.2.2 Sales Value of Lower Limb Exoskeleton by Regions
    2.3 Production Market of Lower Limb Exoskeleton by Regions
    2.4 Global Market Forecast of Lower Limb Exoskeleton 2022-2026
        2.4.1 Global Market Forecast of Lower Limb Exoskeleton 2022-2026
        2.4.2 Market Forecast of Lower Limb Exoskeleton by Regions 2022-2026
Chapter 3 Global Market Status and Forecast by Types
    3.1 Sales Volume of Lower Limb Exoskeleton by Types
    3.2 Sales Value of Lower Limb Exoskeleton by Types
    3.3 Market Forecast of Lower Limb Exoskeleton by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
    4.1 Global Sales Volume of Lower Limb Exoskeleton by Downstream Industry
    4.2 Global Market Forecast of Lower Limb Exoskeleton by Downstream Industry
Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry
    5.1 North America Lower Limb Exoskeleton Market Status by Countries
        5.1.1 North America Lower Limb Exoskeleton Sales by Countries (2016-2021)
        5.1.2 North America Lower Limb Exoskeleton Revenue by Countries (2016-2021)
        5.1.3 United States Lower Limb Exoskeleton Market Status (2016-2021)
        5.1.4 Canada Lower Limb Exoskeleton Market Status (2016-2021)
        5.1.5 Mexico Lower Limb Exoskeleton Market Status (2016-2021)
    5.2 North America Lower Limb Exoskeleton Market Status by Manufacturers
    5.3 North America Lower Limb Exoskeleton Market Status by Type (2016-2021)
        5.3.1 North America Lower Limb Exoskeleton Sales by Type (2016-2021)
        5.3.2 North America Lower Limb Exoskeleton Revenue by Type (2016-2021)
    5.4 North America Lower Limb Exoskeleton Market Status by Downstream Industry (2016-2021)
Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry
    6.1 Europe Lower Limb Exoskeleton Market Status by Countries
        6.1.1 Europe Lower Limb Exoskeleton Sales by Countries (2016-2021)
        6.1.2 Europe Lower Limb Exoskeleton Revenue by Countries (2016-2021)
        6.1.3 Germany Lower Limb Exoskeleton Market Status (2016-2021)
        6.1.4 UK Lower Limb Exoskeleton Market Status (2016-2021)
        6.1.5 France Lower Limb Exoskeleton Market Status (2016-2021)
        6.1.6 Italy Lower Limb Exoskeleton Market Status (2016-2021)
        6.1.7 Russia Lower Limb Exoskeleton Market Status (2016-2021)
        6.1.8 Spain Lower Limb Exoskeleton Market Status (2016-2021)
        6.1.9 Benelux Lower Limb Exoskeleton Market Status (2016-2021)
    6.2 Europe Lower Limb Exoskeleton Market Status by Manufacturers
    6.3 Europe Lower Limb Exoskeleton Market Status by Type (2016-2021)
        6.3.1 Europe Lower Limb Exoskeleton Sales by Type (2016-2021)
        6.3.2 Europe Lower Limb Exoskeleton Revenue by Type (2016-2021)
    6.4 Europe Lower Limb Exoskeleton Market Status by Downstream Industry (2016-2021)
Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry
    7.1 Asia Pacific Lower Limb Exoskeleton Market Status by Countries
        7.1.1 Asia Pacific Lower Limb Exoskeleton Sales by Countries (2016-2021)
        7.1.2 Asia Pacific Lower Limb Exoskeleton Revenue by Countries (2016-2021)
        7.1.3 China Lower Limb Exoskeleton Market Status (2016-2021)
        7.1.4 Japan Lower Limb Exoskeleton Market Status (2016-2021)
        7.1.5 India Lower Limb Exoskeleton Market Status (2016-2021)
        7.1.6 Southeast Asia Lower Limb Exoskeleton Market Status (2016-2021)
        7.1.7 Australia Lower Limb Exoskeleton Market Status (2016-2021)
    7.2 Asia Pacific Lower Limb Exoskeleton Market Status by Manufacturers
    7.3 Asia Pacific Lower Limb Exoskeleton Market Status by Type (2016-2021)
        7.3.1 Asia Pacific Lower Limb Exoskeleton Sales by Type (2016-2021)
        7.3.2 Asia Pacific Lower Limb Exoskeleton Revenue by Type (2016-2021)
    7.4 Asia Pacific Lower Limb Exoskeleton Market Status by Downstream Industry (2016-2021)
Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry
    8.1 Latin America Lower Limb Exoskeleton Market Status by Countries
        8.1.1 Latin America Lower Limb Exoskeleton Sales by Countries (2016-2021)
        8.1.2 Latin America Lower Limb Exoskeleton Revenue by Countries (2016-2021)
        8.1.3 Brazil Lower Limb Exoskeleton Market Status (2016-2021)
        8.1.4 Argentina Lower Limb Exoskeleton Market Status (2016-2021)
        8.1.5 Colombia Lower Limb Exoskeleton Market Status (2016-2021)
    8.2 Latin America Lower Limb Exoskeleton Market Status by Manufacturers
    8.3 Latin America Lower Limb Exoskeleton Market Status by Type (2016-2021)
        8.3.1 Latin America Lower Limb Exoskeleton Sales by Type (2016-2021)
        8.3.2 Latin America Lower Limb Exoskeleton Revenue by Type (2016-2021)
    8.4 Latin America Lower Limb Exoskeleton Market Status by Downstream Industry (2016-2021)
Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry
    9.1 Middle East and Africa Lower Limb Exoskeleton Market Status by Countries
        9.1.1 Middle East and Africa Lower Limb Exoskeleton Sales by Countries (2016-2021)
        9.1.2 Middle East and Africa Lower Limb Exoskeleton Revenue by Countries (2016-2021)
        9.1.3 Middle East Lower Limb Exoskeleton Market Status (2016-2021)
        9.1.4 Africa Lower Limb Exoskeleton Market Status (2016-2021)
    9.2 Middle East and Africa Lower Limb Exoskeleton Market Status by Manufacturers
    9.3 Middle East and Africa Lower Limb Exoskeleton Market Status by Type (2016-2021)
        9.3.1 Middle East and Africa Lower Limb Exoskeleton Sales by Type (2016-2021)
        9.3.2 Middle East and Africa Lower Limb Exoskeleton Revenue by Type (2016-2021)
    9.4 Middle East and Africa Lower Limb Exoskeleton Market Status by Downstream Industry (2016-2021)
Chapter 10 Market Driving Factor Analysis of Lower Limb Exoskeleton
    10.1 Global Economy Situation and Trend Overview
    10.2 Lower Limb Exoskeleton Downstream Industry Situation and Trend Overview
Chapter 11 Lower Limb Exoskeleton Market Competition Status by Major Manufacturers
    11.1 Production Volume of Lower Limb Exoskeleton by Major Manufacturers
    11.2 Production Value of Lower Limb Exoskeleton by Major Manufacturers
    11.3 Basic Information of Lower Limb Exoskeleton by Major Manufacturers
        11.3.1 Headquarters Location and Established Time of Lower Limb Exoskeleton Major Manufacturer
        11.3.2 Employees and Revenue Level of Lower Limb Exoskeleton Major Manufacturer
    11.4 Market Competition News and Trend
        11.4.1 Merger, Consolidation or Acquisition News
        11.4.2 Investment or Disinvestment News
        11.4.3 New Product Development and Launch
Chapter 12 Lower Limb Exoskeleton Major Manufacturers Introduction and Market Data
    12.1 Cyberdyne
        12.1.1 Company profile
        12.1.2 Representative Lower Limb Exoskeleton Product
        12.1.3 Lower Limb Exoskeleton Sales, Revenue, Price and Gross Margin of Cyberdyne
    12.2 Hocoma
        12.2.1 Company profile
        12.2.2 Representative Lower Limb Exoskeleton Product
        12.2.3 Lower Limb Exoskeleton Sales, Revenue, Price and Gross Margin of Hocoma
    12.3 ReWalkRobotics
        12.3.1 Company profile
        12.3.2 Representative Lower Limb Exoskeleton Product
        12.3.3 Lower Limb Exoskeleton Sales, Revenue, Price and Gross Margin of ReWalkRobotics
    12.4 EksoBionics
        12.4.1 Company profile
        12.4.2 Representative Lower Limb Exoskeleton Product
        12.4.3 Lower Limb Exoskeleton Sales, Revenue, Price and Gross Margin of EksoBionics
    12.5 LockHeedMartin
        12.5.1 Company profile
        12.5.2 Representative Lower Limb Exoskeleton Product
        12.5.3 Lower Limb Exoskeleton Sales, Revenue, Price and Gross Margin of LockHeedMartin
    12.6 ParkerHannifin
        12.6.1 Company profile
        12.6.2 Representative Lower Limb Exoskeleton Product
        12.6.3 Lower Limb Exoskeleton Sales, Revenue, Price and Gross Margin of ParkerHannifin
    12.7 suitX(USBionics)
        12.7.1 Company profile
        12.7.2 Representative Lower Limb Exoskeleton Product
        12.7.3 Lower Limb Exoskeleton Sales, Revenue, Price and Gross Margin of suitX(USBionics)
    12.8 Hyundai
        12.8.1 Company profile
        12.8.2 Representative Lower Limb Exoskeleton Product
        12.8.3 Lower Limb Exoskeleton Sales, Revenue, Price and Gross Margin of Hyundai
    12.9 Panasonic
        12.9.1 Company profile
        12.9.2 Representative Lower Limb Exoskeleton Product
        12.9.3 Lower Limb Exoskeleton Sales, Revenue, Price and Gross Margin of Panasonic
    12.10 InteractiveMotionTechnologies
        12.10.1 Company profile
        12.10.2 Representative Lower Limb Exoskeleton Product
        12.10.3 Lower Limb Exoskeleton Sales, Revenue, Price and Gross Margin of InteractiveMotionTechnologies
    12.11 Myomo
        12.11.1 Company profile
        12.11.2 Representative Lower Limb Exoskeleton Product
        12.11.3 Lower Limb Exoskeleton Sales, Revenue, Price and Gross Margin of Myomo
    12.12 B-TEMIAInc.
        12.12.1 Company profile
        12.12.2 Representative Lower Limb Exoskeleton Product
        12.12.3 Lower Limb Exoskeleton Sales, Revenue, Price and Gross Margin of B-TEMIAInc.
    12.13 AlterG
        12.13.1 Company profile
        12.13.2 Representative Lower Limb Exoskeleton Product
        12.13.3 Lower Limb Exoskeleton Sales, Revenue, Price and Gross Margin of AlterG
Chapter 13 Upstream and Downstream Market Analysis of Lower Limb Exoskeleton
    13.1 Industry Chain of Lower Limb Exoskeleton
    13.2 Upstream Market and Representative Companies Analysis
    13.3 Downstream Market and Representative Companies Analysis
Chapter 14 Cost and Gross Margin Analysis of Lower Limb Exoskeleton
    14.1 Cost Structure Analysis of Lower Limb Exoskeleton
    14.2 Raw Materials Cost Analysis of Lower Limb Exoskeleton
    14.3 Labor Cost Analysis of Lower Limb Exoskeleton
    14.4 Manufacturing Expenses Analysis of Lower Limb Exoskeleton
Chapter 15 Report Conclusion
Chapter 16 Research Methodology and Reference
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Reference